New Services: Strategic Commercialization Support
In February, Facet will be launching a Strategic Commercialization [...]
New Services: Strategic Statistical Support
Facet’s new Strategic Statistical Services group uses statistical principles [...]
Facet By The Numbers – Q4 2023
FACET BY THE NUMBERS Early-stage development highlights: 3 IND [...]
FDA Round Up – Q4 2023
FDA ROUNDUP: New FDA guidance: Stimulant Use Disorders: Developing [...]
Did You Know – Q4 2023
DID YOU KNOW? Facet’s strategic and tactical regulatory affairs, [...]
Spotlight On Rare Disease Development – Q4 2023
FDA Support for clinical Trials Advancing Rare disease Therapeutics [...]
Spotlight On – Q4 2023
RECENT FACET SUCCESSES - JUST A FEW HIGHLIGHTS FACET [...]
From The Corner Office
Ken VanLuvanee, President & CEO It was a [...]
Facet Life Sciences Quarterly Update Q4 – 2023
From The Corner Office Ken VanLuvanee, President [...]
Getting To and Through FDA with Jason Mercer
We recently caught up with Jason Mercer, Strategic Program [...]
gET sOCIAL